Assenagon Asset Management S.A.

Position in OCUL — Ocular Therapeutix, Inc

CIK 1546007 SENNINGERBERG, N4

Position in OCUL

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$447,792

+$61,560 QoQ

Shares Held

45,600

0.0% QoQ

Ownership

0.021%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#133

of 257 holders

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Assenagon Asset Management S.A. holds $1,943,463,989 across 69 Biotechnology names. OCUL ranks #59 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	759,564	$377,298,225
2	ROIV	Roivant Sciences Ltd.	8,362,952	$295,964,871
3	REGN	Regeneron Pharmaceuticals, Inc.	244,927	$152,721,781
4	AXSM	Axsome Therapeutics, Inc.	454,682	$111,292,513
5	BMRN	Biomarin Pharmaceutical Inc	1,762,086	$100,826,560
6	HALO	Halozyme Therapeutics, Inc.	997,643	$78,085,517
7	MDGL	Madrigal Pharmaceuticals, Inc.	124,214	$66,696,707
8	TARS	Tarsus Pharmaceuticals, Inc.	947,495	$59,635,335

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$447,792	45,600	0.0%	Shares	Sole	2026-07-08
2026-03-31	$386,232	45,600	-92.7%	Shares	Sole	2026-04-20
2025-12-31	$7,536,681	620,814	+1261.4%	Shares	Sole	2026-01-09
2025-09-30	$533,064	45,600	-76.5%	Shares	Sole	2025-10-07
2025-06-30	$1,797,536	193,700	-43.3%	Shares	Sole	2025-07-11
2025-03-31	$2,505,394	341,800	-87.9%	Shares	Sole	2025-04-15
2024-09-30	$24,584,077	2,825,756	+20535.0%	Shares	Sole	2024-10-23
2021-12-31	$95,447	13,694	-30.1%	Shares	Sole	2022-02-01
2021-09-30	$195,970	19,597	-79.8%	Shares	Sole	2021-10-19
2021-06-30	$1,375,658	97,014	+1.2%	Shares	Sole	2021-07-15
2021-03-31	$1,573,636	95,895	0.0%	Shares	Sole	2021-04-26
2020-12-31	$1,985,026	95,895	—	Shares	Sole	2021-02-01
No filing history on record for this holder in this stock.